First International Symposium on
TRANSDISCIPLINARY APPROACHES FOR NEUROBLASTOMA THERAPY
6 - 7th February 2023 · Barcelona
#Neuroblastoma
Transdisciplinary Approaches for Neuroblastoma therapy symposium
This networking event brings together experts from different fields but with the same objective- to join forces to fight NB and accelerate new treatment’s discovery. To this end, the main aim of the networking event is to share knowledge between physicians, researchers, and members of patient advocacy organizations of different fields and expertise, to find new common solutions against neuroblastoma, and build up a research consortium to actively participate in the Europe’s Beating Cancer Plan.
The symposium will be held at the Sant Joan de Deu Hospital in the greater Barcelona area (Spain); it will be carried out in four sessions to discuss new advancements in Neuroblastoma characterization and modeling, cutting-edge technologies, and current strategies for Neurblastoma therapy.
The network event will serve to bring knowledge for all participants, build up new research networks, and disseminate the event conclusions to the general public, thanks to the support of the Association of Families and Friends of Children with Neuroblastoma (NEN).
The symposium encourages the participation of Early Career Researchers and enables involvement in the network of usually underrepresented countries in Europe.
6-7
February 2023
Important dates
Deadline for abstracts submission: 20th January 10:30 a.M. Closed (notification 24th January)
Registration deadline: 1st February (depending on capacity) Closed: Full capacity
Venue
PCCB Auditorium
Pediatric Cancer Center Barcelona
Carrer de Santa Rosa, 39
08950 Barcelona
Local committee
Aranzazu Villasante, Institute for Bioengineering of Catalonia (IBEC)
Clara Alcon, Institute for Bioengineering of Catalonia (IBEC)
Silvia Mateo, Hospital Sant Joan de Deu (SJD)
Jara Martín,Hospital Sant Joan de Deu (SJD)
Joaquín Molí, Association of Families and Friends of Children with Neuroblastoma (NEN)
PONENTES · 15 de noviembre
PROGRAMME
| 8:30 | Registration |
| 9:00 – 9:30 | [OPENING CEREMONY] Jaume Mora Scientific Director of the Pediatric Cancer Center Barcelona (PCCB) at Hospital Sant Joan de Deu, Barcelona, Spain Josep Samitier Director of the Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain Joaquín Molí President of the Association of Families and Friends of Children with Neuroblastoma (NEN) |
SESSION 1: NEUROBLASTOMA BIOLOGY AND MODELING (I) Chairs: | |
| 9:30 – 9:50 | Targeting mitochondria to overcome neuroblastoma multidrug resistance Jan Skoda |
| 9:50 – 10:00 | Characterization of the invasive properties and plasticity of Neural Crest Stem-like Cells in neuroblastoma tumours Francisco M. Vega |
| 10:00 – 10:20 | Reprogramming neuroblastoma metabolism through extracellular vesicle-mediated communication. Olga Piskareva RCSI University of Health and Medical Sciences, Dublin, Ireland |
| 10:20 – 10:30 | The splicing inhibitor isoginkgetin potentiates the effect of vincristine in MYCN-amplified neuroblastoma cells. Melinda Halasz |
| 10:30 – 10:50 | Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low versus high-risk neuroblastoma tumors. Oscar Bedoya-Reina |
| 10:50 – 11:10 | Coffee Break |
SESSION 2: NEUROBLASTOMA BIOLOGY AND MODELING (II) Chairs: | |
| 11:10 – 11:30 | Bioengineered models to study the alternative vasculature in neuroblastoma Aranzazu Villasante |
| 11:30 – 11:40 | Spatial analysis of cell clusters in silk-fibroin 3D model updates the importance of vitronectin in neuroblastoma Isaac Vieco-Martí |
| 11:40 – 12:10 | [INVITED SPEAKER] Patient-derived models for improved neuroblastoma treatment Daniel Bexell Lund University, Lund, Sweden |
| 12:10 – 12:20 | Spatial decoding of neuroblastoma Teodora Randelovic |
| 12:20 – 12:50 | [INVITED SPEAKER] Digital Twins for precision neuroblastoma diagnosis and treatment Walter Kolch University College Dublin (UCD), Dublin, Ireland |
| 12:50 – 13:50 | Lunch + meet the mentor |
| 13:50 – 15:10 | Poster Session 3-minute Flash poster presentation |
[Session 3: CUTTING-EDGE THERAPIES] Chairs: | |
| 15:10 – 15:30 | Juan Gallo International Iberian Nanotechnology Laboratory (INL), Braga, Portugal |
| 15:30 – 16:00 | Tumor- and vascular-targeted liposomal nanoparticles for neuroblastoma therapy Fabio Pastorino |
| 16:00 – 16:10 | Bioinspired Synthetic Cells for Precision Nanomedicine Cesar Rodriguez-Emmenegger |
| 16:10 – 16:40 | [INVITED SPEAKER] Towards tailored antitumor T-cell therapies Alena Gros Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
| 16:40 – 16:50 | Nanomedicines for the treatment of neuroblastoma Souhaila H. El Moukhtari |
| 16:50 – 17:00 | Quatsomes are novel platform to deliver RNA-based therapies for Neuroblastoma Ariadna Boloix |
| 17:00 – 17:30 | [INVITED SPEAKER] Aptamers: a new emerging tool of therapeutic agents for targeted cancer therapy Oscar Martinez Tirado Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain |
| 18:30 – 20:00 | Welcome reception and dinner (at the same venue) |
[Session 4: CLINICAL APPROACHES] Chairs: Session scribe: | |
| 9:00 – 9:20 | Frank Westermann · German Cancer Research Center (DKFZ), Heidelberg, Germany |
| 9:20 – 9:30 | NeuVac, a novel mRNA cancer vaccine delivered using RALA technology, stimulates a greater immune response compared to DNA vaccine counterpart. Ellen King |
| 9:30 – 10:00 | [INVITED SPEAKER] Clonal evolution in neuroblastoma – an important player in tumor progression Gudrun Schleiermacher Institut Curie, Paris, France |
| 10:00 – 10:10 | Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in High-Risk Neuroblastoma Ronja Struck |
| 10:10 – 10:40 | [INVITED SPEAKER] Theranostics-systemic radiotherapy Max van Noesel Princess Maxima center for pediatric oncology, Utrecht, The netherlands |
| 10:40 – 11:00 | Coffee Break |
| 11:00 – 11:45 | [KEYNOTE SPEAKER] How do we translate research findings into patient benefit in 2023? Lucas Moreno Division Head, Paediatric Oncology & Haematology at Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain Chairs: |
| 11:45 – 12:15 | Round table. Final remarks |